These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 2124721)

  • 1. [Hormonal treatments of prostate cancer].
    Kuhn JM
    Rev Prat; 1990 Nov; 40(25):2357-62. PubMed ID: 2124721
    [No Abstract]   [Full Text] [Related]  

  • 2. Endocrine treatment of prostate cancer: standard treatment and new perspectives.
    Boccardo F; Pace M
    In Vivo; 1993; 7(5):423-4. PubMed ID: 8110985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced prostate cancer. Hormonal treatment.
    de la Haba-Rodríguez J
    Tunis Med; 2005 Dec; 83 Suppl 12():71-3. PubMed ID: 16430072
    [No Abstract]   [Full Text] [Related]  

  • 4. Hormonal management of advanced adenocarcinoma of the prostate.
    Miles BJ
    Henry Ford Hosp Med J; 1989; 37(1):16-8. PubMed ID: 2670839
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hormone therapy for prostate cancer].
    Théodore C
    Bull Cancer; 2004 Jan; 91(1):69-74. PubMed ID: 14975807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hormone therapy in prostate cancer: clinical results].
    Morote-Robles J
    Rev Esp Fisiol; 1990 Mar; 46(1):59-62. PubMed ID: 1697693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New approach in the treatment of prostatic cancer: combined use of a LHRH agonist and an androgen antagonist].
    Labrie F; Dupont A; Belanger A; Lefebvre FA; Raynaud JP
    J Pharmacol; 1983; 14 Suppl 3():117-35. PubMed ID: 6423907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New possibilities in the hormonal therapy of metastatic carcinoma of the prostate].
    Cicin-Sain D; Pasini J
    Lijec Vjesn; 1989 Nov; 111(11):405-7. PubMed ID: 2699907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete androgen blockade for the treatment of prostate cancer.
    Labrie F; Dupont A; Belanger A
    Important Adv Oncol; 1985; ():193-217. PubMed ID: 3916740
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hormonal therapy (medical orchiectomy) in prostatic carcinoma].
    Studer UE; Münch D
    Schweiz Med Wochenschr; 1990 Jun; 120(24):881-7. PubMed ID: 2193381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The potential hormonal therapy of prostatic carcinoma].
    Studer UE; Altwein J; Bartsch G
    Urologe A; 1991 Sep; 30(5):310-6. PubMed ID: 1949440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compliance with hormonal treatment for prostate cancer.
    Kaisary AV
    Br J Hosp Med; 1996 Mar 20-Apr 2; 55(6):359-66. PubMed ID: 8696636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nonsteroidal effects of diethylstilbestrol: the rationale for androgen deprivation therapy without estrogen deprivation in the treatment of prostate cancer.
    Scherr DS; Pitts WR
    J Urol; 2003 Nov; 170(5):1703-8. PubMed ID: 14532759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of advanced prostate cancer.
    Lynch JH
    J Fam Pract; 1993 Nov; 37(5):488-94. PubMed ID: 7693859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine therapy for prostate cancer.
    Damber JE
    Acta Oncol; 2005; 44(6):605-9. PubMed ID: 16165920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of advanced cancer of the prostate.
    Orovan WL
    Can J Surg; 1989 Sep; 32(5):315-6. PubMed ID: 2670160
    [No Abstract]   [Full Text] [Related]  

  • 17. Nonsteroidal anti-androgens: role in treating advanced prostate cancer.
    Newton M; Kosier JH
    Urol Nurs; 1998 Mar; 18(1):56-7, 83. PubMed ID: 9582897
    [No Abstract]   [Full Text] [Related]  

  • 18. Initiation of LHRH monotherapy for prostate cancer.
    Milsted RA
    Prog Clin Biol Res; 1989; 303():69-74. PubMed ID: 2528742
    [No Abstract]   [Full Text] [Related]  

  • 19. Controversies surrounding hormonal deprivation.
    Denis LJ
    Acta Urol Belg; 1996 May; 64(2):81-4. PubMed ID: 8701819
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: luteinizing hormone-releasing hormone agonist effects on skeletal muscle: how hormonal therapy in prostate cancer affects muscular strength.
    Marcora S; Oliver S; Callow N; Lemmey A; Stuart N
    J Urol; 2005 Nov; 174(5):2068-9. PubMed ID: 16217402
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.